Christy Shaffer, PhD, a receptor pharmacologist by training, is a seasoned CEO and entrepreneur with over 25 years of industry experience. She has raised over $500M to date for multiple companies. As a Managing Director of Hatteras Discovery, Christy was responsible for leading the seed rounds for a number of companies, including several in the ophthalmology field over the past 5 years. The Hatteras Venture Partner’s portfolio includes Clearside Biomedical (NASDAQ: CLSD), GrayBug Vision and Trefoil Therapeutics and she serves as Chair of these corporate boards. She is a general partner at Hatteras Venture Partners, based in Durham, North Carolina. She also serves on a number of non-profit boards and is a champion of STEM education and innovation.